J. Scott Miners

Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease

J. Scott Miners, Isabel Schulz, Seth Love · Journal of Cerebral Blood Flow & Metabolism · 2017 · 219 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology

Patrick G. Kehoe, Steffenny Wong, Noura Al Mulhim et al. · Alzheimer s Research & Therapy · 2016 · 208 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Angiotensin‐converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE‐1 to cerebral amyloid angiopathy

J. Scott Miners, Elizabeth Ashby, Zoë Van Helmond et al. · Neuropathology and Applied Neurobiology · 2007 · 163 citations

Life Sciences, Neurology, Neuroscience +17

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Charles E. Evans, J. Scott Miners, Giulia Piva et al. · Acta Neuropathologica · 2020 · 154 citations · Full text

Medicine, Neurology, Neuroscience +17

Decreased Expression and Activity of Neprilysin in Alzheimer Disease Are Associated With Cerebral Amyloid Angiopathy

J. Scott Miners, Zoë Van Helmond, Katy Chalmers et al. · Journal of Neuropathology & Experimental Neurology · 2006 · 153 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17